- Home
- ELVN vs PARR Comparison
ELVN vs PARR Comparison
Compare ELVN & PARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- PARR
- Stock Information
- Founded
- ELVN 2016
- PARR 1984
- Country
- ELVN United States
- PARR United States
- Employees
- ELVN N/A
- PARR N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- PARR Integrated oil Companies
- Sector
- ELVN Health Care
- PARR Energy
- Exchange
- ELVN Nasdaq
- PARR Nasdaq
- Market Cap
- ELVN 1.2B
- PARR 1.4B
- IPO Year
- ELVN 2020
- PARR N/A
- Fundamental
- Price
- ELVN $19.32
- PARR $31.98
- Analyst Decision
- ELVN Strong Buy
- PARR Buy
- Analyst Count
- ELVN 5
- PARR 7
- Target Price
- ELVN $41.20
- PARR $26.68
- AVG Volume (30 Days)
- ELVN 410.5K
- PARR 1.1M
- Earning Date
- ELVN 08-12-2025
- PARR 08-05-2025
- Dividend Yield
- ELVN N/A
- PARR N/A
- EPS Growth
- ELVN N/A
- PARR N/A
- EPS
- ELVN N/A
- PARR N/A
- Revenue
- ELVN N/A
- PARR $7,738,658,000.00
- Revenue This Year
- ELVN N/A
- PARR N/A
- Revenue Next Year
- ELVN N/A
- PARR N/A
- P/E Ratio
- ELVN N/A
- PARR N/A
- Revenue Growth
- ELVN N/A
- PARR N/A
- 52 Week Low
- ELVN $13.30
- PARR $11.86
- 52 Week High
- ELVN $30.03
- PARR $35.32
- Technical
- Relative Strength Index (RSI)
- ELVN 40.65
- PARR 57.90
- Support Level
- ELVN $21.25
- PARR $30.83
- Resistance Level
- ELVN $22.83
- PARR $33.28
- Average True Range (ATR)
- ELVN 1.42
- PARR 1.29
- MACD
- ELVN -0.35
- PARR -0.46
- Stochastic Oscillator
- ELVN 5.60
- PARR 25.61
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About PARR Par Pacific Holdings Inc.
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.